rs114396665
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_014956.5(CEP164):c.1480C>A(p.Pro494Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00123 in 1,603,380 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P494P) has been classified as Benign.
Frequency
Consequence
NM_014956.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEP164 | NM_014956.5 | c.1480C>A | p.Pro494Thr | missense_variant | 13/33 | ENST00000278935.8 | NP_055771.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEP164 | ENST00000278935.8 | c.1480C>A | p.Pro494Thr | missense_variant | 13/33 | 1 | NM_014956.5 | ENSP00000278935.3 | ||
CEP164 | ENST00000533675.5 | n.1735C>A | non_coding_transcript_exon_variant | 9/27 | 2 | |||||
CEP164 | ENST00000533706.5 | n.804C>A | non_coding_transcript_exon_variant | 6/27 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00649 AC: 988AN: 152122Hom.: 15 Cov.: 33
GnomAD3 exomes AF: 0.00153 AC: 341AN: 222628Hom.: 4 AF XY: 0.00119 AC XY: 144AN XY: 121308
GnomAD4 exome AF: 0.000676 AC: 981AN: 1451140Hom.: 7 Cov.: 30 AF XY: 0.000583 AC XY: 420AN XY: 720824
GnomAD4 genome AF: 0.00650 AC: 990AN: 152240Hom.: 15 Cov.: 33 AF XY: 0.00648 AC XY: 482AN XY: 74436
ClinVar
Submissions by phenotype
CEP164-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 05, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Nephronophthisis 15 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at